Work With Us
caVos generates computationally-designed mRNA candidates and formulation models. We cannot validate them alone — we need wet-lab partners, CNS-experienced pharma teams, and academic co-investigators. If that describes your lab or organization, we want to talk.
Who We Work With
Three collaboration models, each addressing a specific gap between our computational capabilities and the experimental work needed to advance the pipeline.
Research Hospitals & Academic Labs
We are looking for partners with iPSC-derived neuronal models or primary cell assay infrastructure for target validation. We provide candidate mRNA sequences and predicted expression profiles; partners provide biological testing capability. Data sharing agreements and co-authorship on publication-ready findings are standard terms we are comfortable with.
Pharma Partners
Licensing and co-development discussions for CVX-001 and CVX-002. We are looking for partners with CNS in vivo capabilities or established neurodegeneration research programs who want early-access to our target rationale and computational candidate series. Conversations start informally — no NDA required for a first call.
Academic Investigators
Joint grant applications with academic groups working in longevity genomics, mRNA therapeutics, or CNS LNP delivery. We contribute computational analysis, candidate sequences, and bioinformatics methodology. Partners contribute experimental design and execution. Appropriate for groups exploring national or international longevity research funding calls.
Send an Inquiry
Tell us about your organization, what you're working on, and what kind of collaboration you have in mind. We read every message. We respond to substantive inquiries — those that show you've read our pipeline — within five business days.
Direct Contact
Prefer direct email? Reach us at:
30 Shlomo Ibn Gabirol Street
Tel Aviv 6407808, Israel
What to Expect
We respond to substantive inquiries within 5 business days. Initial conversations are informal and exploratory — no NDAs required for a first call. We are direct about what our pipeline is and what stage it is at. We will not oversell what we have.